{
    "clinical_study": {
        "@rank": "129518", 
        "arm_group": [
            {
                "arm_group_label": "EMLA  analgesic cream", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients who have had EMLA analgesic cream applied to area before pacemaker implantation"
            }, 
            {
                "arm_group_label": "Routine treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients who have received routine treatment (Dormicum 2.5 mg and Pethidine 25 mg)  before and during pacemaker implantation"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators believe that the local anesthetic  EMLA (Lidocaine 2.5% and Prilocaine\n      2.5%) cream will lessen pain and reduce the need for anesthesia and analgesia, when\n      implanting a permanent pacemaker."
        }, 
        "brief_title": "Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pacemaker Implantation", 
            "Pain"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients undergoing pacemaker implantation\n\n        Exclusion Criteria:\n\n          -  Dementia Patients\n\n          -  Psychiatric Patients\n\n          -  Unconscious Patients\n\n          -  Patients with sensitivity to EMLA"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02016976", 
            "org_study_id": "0094-13-HYMC"
        }, 
        "intervention": [
            {
                "arm_group_label": "EMLA  analgesic cream", 
                "intervention_name": "EMLA Analgesic Cream", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Routine treatment", 
                "description": "Routine anesthesia and analgesia ( Dormicum 2.5 mg and Pethidine 25 mg )normally given to patients before and during pacemaker implantation", 
                "intervention_name": "Dormicum 2.5 mg and  Pethidine  25 mg", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Analgesics", 
                "Meperidine", 
                "Anesthetics, Local", 
                "EMLA", 
                "Midazolam"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 19, 2013", 
        "location": {
            "contact": {
                "email": "anatglass1@gmail.com", 
                "last_name": "Anat Glass, RN, MA", 
                "phone": "972-52-8335558"
            }, 
            "facility": {
                "address": {
                    "city": "Hadera", 
                    "country": "Israel", 
                    "zip": "38100"
                }, 
                "name": "Hillel Yaffe Medical Center"
            }, 
            "investigator": {
                "last_name": "Anat Glass, RN, MA", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "anatglass1@gmail.com", 
            "last_name": "Anat Glass, RN, MA", 
            "phone": "972-52-8335558"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "EMLA anesthetic cream will be applied to area where pacemaker is to be implanted.  Pain reduction will be measured using the visual analog scale  (VAS) at three intervals.", 
            "measure": "Pain reduction", 
            "safety_issue": "No", 
            "time_frame": "One hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02016976"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hillel Yaffe Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hillel Yaffe Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}